According to BridgeBio Pharma 's latest financial reports the company's current earnings (TTM) are -$0.58 B. In 2022 the company made an earning of -$0.41 B an increase over its 2021 earnings that were of -$0.54 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.58 B | 41.5% |
2022 | -$0.41 B | -25.1% |
2021 | -$0.54 B | 15.11% |
2020 | -$0.47 B | 67.55% |
2019 | -$0.28 B | 67.65% |
2018 | -$0.17 B |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -$0.19 B | -67.77% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -$18.95 M | -96.69% | ๐บ๐ธ USA |